#Israel #AI Technology #Ramat Gan #SmartScan #Pulsenmore

Pulsenmore's Significant AI Grant Announcement

Pulsenmore Ltd., a frontrunner in the realm of home ultrasound technology, has recently garnered significant attention with the announcement of a $1.27 million grant approved by the Israel Innovation Authority. This funding is intended for their innovative project, the SmartScan AI program, and marks the second grant received by the company in just one month, bringing the total to approximately $1.6 million for their AI initiatives.

Empowering Home Ultrasound Technology

The primary aim of the SmartScan AI initiative is to revolutionize how ultrasound scans are conducted at home. By merging artificial intelligence with real-time guidance for users, the project seeks to facilitate a seamless experience for pregnant women performing ultrasound scans independently. Currently, the quality of ultrasound images largely depends on the skill of the operator, which can lead to inconsistent results. Through the integration of AI, Pulsenmore aims to greatly enhance the image acquisition process and overall scan quality, making home ultrasound more reliable and accessible.

Dr. Elazar Sonnenschein, the founder and CEO of Pulsenmore, emphasizes the importance of this technology, stating, "This second grant within a month serves as a strong endorsement not just for our technology but for our strategic vision. Our goal is to build an AI framework that spans the entire ultrasound process, which will enable us to handle a larger volume of home examinations efficiently without needing to proportionally increase clinical resources."

SmartScan AI's Target Applications

SmartScan AI is set to cater specifically to three key applications within women's health: monitoring fetal well-being and growth, providing feedback on fetal positioning during the later stages of pregnancy, and assisting with monitoring during fertility treatments. These applications are designed to empower women with immediate insights about their health and that of their unborn child, thereby enhancing the prenatal care experience.

The program intends to leverage its learnings from over 250,000 clinical scans stored on the Pulsenmore platform. This vast dataset will help in optimizing the advanced AI models necessary for swift and effective processing using Edge AI technology, thereby streamlining the overall workflow in clinical settings.

Complementary Programs to Boost Efficiency

This additional funding follows Pulsenmore's previous selection in July 2026 for a joint initiative launched by the Israel Innovation Authority and the Ministry of Health. This collaboration focuses on developing AI applications that can enhance the efficiency of clinical workflows in healthcare environments. With this strategically aligned approach, Pulsenmore aims to support an increasing number of home ultrasound examinations while ensuring high-quality outcomes.

Conclusion

In conclusion, Pulsenmore Ltd. is positioning itself at the forefront of healthcare innovation with its SmartScan AI program. The latest grants from the Israel Innovation Authority not only affirm the viability of their AI-oriented solutions but also promise to pave the way for a more patient-centric approach in maternal health management. By focusing on advanced technology integration, Pulsenmore aims to bridge the gap between home healthcare and traditional clinical environments, enhancing the quality and accessibility of prenatal care for women worldwide.